|Bid||10,100.00 x 0|
|Ask||11,000.00 x 0|
|Day's Range||10,808.00 - 10,932.00|
|52 Week Range||9,399.00 - 12,828.45|
|Beta (5Y Monthly)||0.19|
|PE Ratio (TTM)||50.02|
|Forward Dividend & Yield||2.39 (2.14%)|
|Ex-Dividend Date||Feb 23, 2023|
|1y Target Est||N/A|
In the latest trading session, Astrazeneca (AZN) closed at $65.61, marking a -0.56% move from the previous day.
There is nothing like a bear market to emphasize the importance of investing in solid, reliable, and steady companies that can deliver consistent revenue and earnings for a long time. Two such companies are AstraZeneca (NASDAQ: AZN) and Visa (NYSE: V). U.K.-based AstraZeneca is a drugmaker with a vast, diversified portfolio of over three-dozen products across six major segments.
Artisan Partners, an investment management company, released its “Artisan Global Equity Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, its Investor Class fund ARTHX returned 15.95%, Advisor Class fund APDHX posted a return of 15.98%, and Institutional Class fund APHHX returned 16.04%, compared to a […]